Supplementary Table S3 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

Supplementary Table S3 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy

<p>Table S3: GO analysis of phosphorylated proteins differentially expressed in αEPHA2-Cond and cIgG-Tr cells.</p>

Gardado en:
Detalles Bibliográficos
Autor Principal: Amr El Zawily (14851115) (author)
Outros autores: Frederick S. Vizeacoumar (14851118) (author), Renuka Dahiya (14851121) (author), Sara L. Banerjee (14851124) (author), Kalpana K. Bhanumathy (14851127) (author), Hussain Elhasasna (14851130) (author), Glinton Hanover (14851133) (author), Jessica C. Sharpe (14851136) (author), Malkon G. Sanchez (14851139) (author), Paul Greidanus (14851142) (author), R. Greg Stacey (14851145) (author), Kyung-Mee Moon (14851148) (author), Ilya Alexandrov (14851151) (author), Juha P. Himanen (14851154) (author), Dimitar B. Nikolov (14851157) (author), Humphrey Fonge (14851160) (author), Aaron P. White (14851163) (author), Leonard J. Foster (8976302) (author), Bingcheng Wang (14851166) (author), Behzad M. Toosi (14851169) (author), Nicolas Bisson (14851172) (author), Tajib A. Mirzabekov (14851175) (author), Franco J. Vizeacoumar (14851178) (author), Andrew Freywald (14851181) (author)
Publicado: 2025
Subjects:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Methods and Technology
Computational Methods
Database resources
Drug Targets
Cell surface receptor drug targets
Proteomics
Systems Biology
Translational Research
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares

Títulos similares